Cell Point (India) (NSE:CELLPOINT) Other Stockholders Equity: ₹556 Mil (As of Mar. 2026)


NSE:CELLPOINT Cell Point (India) Ltd NSE:CELLPOINT
76 GF Score
Price ₹15.35
GF Value ₹34.81
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Cell Point (India) Other Stockholders Equity?

Cell Point (India) NSE:CELLPOINT 76 Other Stockholders Equity is ₹556 Mil as of Mar. 2026. GuruFocus rates NSE:CELLPOINT with a GF Score™ of 76/100 and a GF Value™ of ₹34.81 (Significantly Undervalued). The stock has 7 warning signs investors should review.

Cell Point (India)'s Other Stockholders Equity for the quarter that ended in Mar. 2026 was ₹556 Mil.

Cell Point (India)'s quarterly Other Stockholders Equity increased from Mar. 2025 (₹0 Mil) to Sep. 2025 (₹558 Mil) but then declined from Sep. 2025 (₹558 Mil) to Mar. 2026 (₹556 Mil).

Cell Point (India)'s annual Other Stockholders Equity stayed the same from Mar. 2024 (₹0 Mil) to Mar. 2025 (₹0 Mil) but then increased from Mar. 2025 (₹0 Mil) to Mar. 2026 (₹556 Mil).

Cell Point (India) Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Cell Point (India)'s Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cell Point (India) Other Stockholders Equity Chart

Cell Point (India) Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Stockholders Equity
Get a 7-Day Free Trial 0.00 64.33 0.00 0.00 556.32

Cell Point (India) Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 557.59 556.32
NSE:CELLPOINT
76GF Score
Cell Point (India) Ltd NSE:CELLPOINT
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cell Point (India) Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of ₹556 Mil mean?
Cell Point (India) (NSE:CELLPOINT) has a Other Stockholders Equity of ₹556 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Cell Point (India) and its competitors.
Is Cell Point (India)'s Other Stockholders Equity too high?
Cell Point (India)'s current Other Stockholders Equity is ₹556 Mil. Overall, Cell Point (India) has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cell Point (India)'s Other Stockholders Equity compare to CASY and WSM?
Cell Point (India)'s Other Stockholders Equity of ₹556 Mil can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Retail - Cyclical company?
A good Other Stockholders Equity depends on the Retail - Cyclical industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Cell Point (India) and its competitors. Cell Point (India)'s current Other Stockholders Equity is ₹556 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cell Point (India) stock overvalued right now?
Based on GuruFocus' analysis, Cell Point (India) (NSE:CELLPOINT) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹34.81, compared to a current price of ₹15.35 — trading 55.9% below its estimated fair value. The current Other Stockholders Equity is ₹556 Mil. Cell Point (India)'s overall GF Score™ is 76/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Cell Point (India) (NSE:CELLPOINT), the current Other Stockholders Equity is ₹556 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cell Point (India) (NSE:CELLPOINT) Overvalued in 2026?

Based on GuruFocus' analysis, Cell Point (India) stock appears to be undervalued. The current stock price of ₹15.35 is trading 55.9% below its estimated GF Value™ of ₹34.81. GuruFocus considers Cell Point (India) to be Significantly Undervalued.

Key valuation signals for NSE:CELLPOINT:

  • Other Stockholders Equity: ₹556 Mil
  • GF Value™: ₹34.81 vs. price of ₹15.35 (55.9% below fair value)
  • GF Score™: 76/100 with 7 warning signs

No single metric tells the full story. See the NSE:CELLPOINT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cell Point (India) Business Description

Address Lalitha Colony, Door No. 30-15-134, Dabagardens, Visakhapatnam, AP, IND, 530020
Cell Point (India) Ltd is engaged in multi-brand retail selling of smartphones, tablets, mobile accessories, and mobile-related products of various brands such as Apple, Samsung, Oppo, Realme, Nokia, Vivo, Xiaomi, Nokia, Redmi, Techno, One Plus, etc. It is also engaged in retail selling of consumer durable electronics goods, smart televisions, smart watches, and air conditioners of various brands such as Xiaomi, Realme, and One Plus among others. The company operates in a single segment and derives revenue from its operations in India.
76GF Score

Get the complete analysis for NSE:CELLPOINT

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹15.35
Price
₹34.81
GF Value